Founded in 1993, Hexagon Nutrition Ltd. is a research-driven nutrition company engaged in developing and manufacturing a wide range of nutritional products, including micronutrient premixes, clinical and wellness nutrition products, therapeutic formulations, and ready-to-use foods. The company serves both consumer and institutional markets through its B2C, B2B2C, and public health-focused nutrition segments.
Hexagon operates three manufacturing facilities in India located at Nashik, Chennai, and Thoothukudi, along with an international manufacturing unit in Tashkent, Uzbekistan. Its product portfolio reaches customers through a strong omnichannel distribution network spanning retail pharmacies, hospitals, e-commerce platforms, online pharmacies, and its own nutrition brands. The company also has a growing international footprint, with exports to more than 75 countries and overseas offices in South Africa, Uzbekistan, and Hong Kong.
Workforce
Backed by dedicated in-house R&D centres in Nashik and Chennai and a workforce of 527 employees as of March 31, 2026, Hexagon focuses on innovation, product quality, and addressing nutritional needs across consumer, healthcare, and public health segments.
| Investory Category | Subscription Percentage | Amount Raised (₹ Crores) |
|---|---|---|
| Qualified Institutional Buyers (QIBs) | 50% | 1,08,01,004 crores |
| Non-Institutional Investors (NIIs) | 35% | 75,60,702.8 crores |
| Retail Individual Investors (RIIs) | 15% | 32,40,301.2 crores |
Hexagon Nutrition’s total income 281.65 by -7.54% and total expenses 0.00 by 0.00%, resulting in an EBITDA 17.17 by -30.99% and a profit after tax (PAT) 5.82 by -52.33% between March 31, 2025 and March 31, 2026.
281.6531 March 2026 | 304.6231 March 2025 | 331.2931 March 2024 |
17.1731 March 2026 | 24.8831 March 2025 | 40.0731 March 2024 |
5.8231 March 2026 | 12.2131 March 2025 | 24.3831 March 2024 |
331.29
298
265
232
199
166
133
99
66
33
0.00
Integrated nutrition business with capabilities spanning research product development manufacturing and distribution.
Diversified portfolio across micronutrient premixes clinical nutrition therapeutic products and ready-to-use nutrition solutions.
Strong domestic and international presence supported by exports to over 75 countries and a wide distribution network across India.
Established supplier to public health and nutrition programs strengthening its position in the micronutrient segment.
Dedicated in-house R&D infrastructure that supports innovation and development of specialized nutrition products.
| Allotment Date | Listing Date | Refund Date |
|---|---|---|
| 10 Jun '26 | 12 Jun '26 | 11 Jun '26 |
| Issue Composition: | |
|---|---|
| Face Value | ₹1 per share |
| Total Issue Size | 2,16,02,008 shares (aggregating up to ₹14,985 crores) |
| Fresh Issue | 0 shares (aggregating up to To be announced) |
| Offer for Sale | 3,08,59,704 shares of ₹1 (aggregating up to ₹3,08,59,704 crores) |
| Issue Type | Book building IPO |
| Post-Issue Shareholding Pattern: | |
|---|---|
| Pre-Issue Shareholding | 89.41 shares |
| Post-Issue Shareholding | 64.29 shares |
| Minimum Lot Size | 333 shares |
| Maximum Lot Size (Retail) | 10,989 shares |
The lot size of Hexagon Nutrition ipo has been designed to ensure broad participation while maintaining optimal price discovery.
404 Global Chambers Adarsh Nagar Link Road Mumbai
Kfin Technologies Ltd.
| Book Running Lead Manager(s) |
|---|
| Cumulative Capital Pvt Ltd | Catalyst Capital Partners Pvt Ltd |